AamAP-S1, AamAP1 [H8K]

General Information


DRACP ID  DRACP02318

Peptide Name   AamAP-S1, AamAP1 [H8K]

Sequence  FLFSLIPKAIGGLISAFK

Sequence Length  18

UniProt ID  G8YYA5 

PubChem CID  71596347 

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane lysis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
PC-3 Prostate carcinoma Carcinoma IC50=28 µM MTT assay 24 h 1
U251 Astrocytoma Carcinoma IC50=29.23 µM MTT assay 24 h 1
LNCaP Prostate carcinoma Carcinoma IC50=25.58 µM MTT assay 24 h 1

Hemolytic Activity  Horse erythrocytes: 53% Hemolysis=100 µM; 52% Hemolysis=80 µM

Normal (non-cancerous) Cytotoxicity  HMEC-1: IC50=40.35 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02318

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C96H152N20O21

Absent amino acids  CDEHMNQRTVWY

Common amino acids  FIL

Mass  222580

Pl  10.81

Basic residues  2

Acidic residues  0

Hydrophobic residues  11

Net charge  2

Boman Index  2606

Hydrophobicity  139.44

Aliphatic Index  141.11

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22484288

Title  Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog

Doi 10.1016/j.peptides.2012.03.016

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_3886

DRACP is developed by Dr.Zheng's team.